Sagent Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGENT, and what generic and branded alternatives to SAGENT drugs are available?
SAGENT has eighty-eight approved drugs.
There is one tentative approval on SAGENT drugs.
Drugs and US Patents for Sagent
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sagent Pharms Inc | FULVESTRANT | fulvestrant | SOLUTION;INTRAMUSCULAR | 205871-001 | Aug 22, 2019 | AO | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Sagent Pharms | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 091597-002 | May 7, 2013 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Sagent Pharms Inc | PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 208674-001 | Feb 16, 2021 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.